Medicine and Dentistry
Rectum Cancer
100%
Neoplasm
74%
Malignant Neoplasm
62%
Colorectal Cancer
57%
Recurrent Disease
43%
Surgery
41%
Colon
39%
Stoma
35%
Surgical Anastomosis
33%
Ulcerative Colitis
32%
Colostomy
30%
Robot-Assisted Surgery
30%
Liver Metastasis
25%
Cancer Cell
24%
Colectomy
24%
Crohn's Disease
24%
Intestine Cancer
23%
Prolapse
23%
Rectocele
23%
Clinician
23%
Rectum Surgery
22%
Bleeding
21%
Retroperitoneal Lymph Node Dissection
20%
Laparoscopic Surgery
19%
Constipation
19%
Cancer Surgery
19%
Postoperative Complication
18%
Rectum Carcinoma
18%
Carcinoma
18%
Colon Cancer
18%
Adenocarcinoma
17%
Da Vinci Surgical System
17%
Surgical Margin
17%
Lower Anterior Resection
16%
Posterior Colporrhaphy
16%
Sigmoid Cancer
15%
Gastrointestinal Stromal Tumor
15%
Defecation Habit
15%
Retrospective Study
15%
Hepatectomy
14%
Pelvis
14%
Surgeon
13%
Propensity Score Matching
12%
Diarrhea
12%
Observational Study
11%
Abdominoperineal Resection
11%
Overall Survival
11%
Prospective Study
11%
Total Mesorectal Excision
10%
Prevalence
10%
Keyphrases
Intestinal Cancer
23%
Tumor
22%
Colorectal Cancer
20%
Crohn's Disease
20%
Japan
19%
Ulcerative Colitis
17%
Rectum
16%
Colon
16%
Colostomy Site
15%
Robotic-assisted
15%
Questionnaire Survey
15%
Propensity Score Analysis
15%
Disease-associated
11%
Stomata
10%
Oncological Outcomes
10%
Rectal Tumor
9%
Robotic Rectal Surgery
9%
Inflammatory Bowel Disease
9%
Confidence Interval
9%
Colectomy
8%
Consecutive Patients
8%
D3 Lymph Node Dissection
8%
High Risk
8%
Advanced Stage
8%
Sigmoid Colon Cancer
7%
Da Vinci Surgical System
7%
Japanese Population
7%
Prospective Cohort Study
7%
FOLFIRINOX
7%
Leiomyosarcoma
7%
Clinical Features
7%
Ligature
7%
Histological Differentiation
7%
Hand-sewn
7%
Functional End-to-end
7%
Cancer-related
7%
Transanal Surgery
7%
Conversion Surgery
7%
Surgical Recurrence
7%
Extraluminal
7%
Duodenal Gastrointestinal Stromal Tumors
7%
Rectovaginal Fistula
7%
Plantation
7%
Peripheral Blood Stem Cells
7%
Levatorplasty
7%
Cart Position
7%
Superior Mesenteric Artery
7%
Conversion Therapy
7%
Double Cancer
7%
Short-term Outcomes
7%